Mercados
Préstamos
Earn
Invertir
VIP
Seguridad
Newsroom
Más
Iniciar sesión
Registrarse
Mercados
Resumen de mercados
Índices y commodities.
Digital Credit
Preferentes de Bitcoin Treasuries.
Acciones de IA
La temática de inteligencia artificial.
Bitcoin Treasuries
Empresas que tienen bitcoin.
Economía
Sectores, mercados globales y tasas.
Portafolios populares
Reportes 13F, smart money.
Préstamos
Pedir prestado
Pide prestado USDT o USDC con tu BTC como garantía, sin venderlo.
ReFi
Pasa tu préstamo respaldado por bitcoin a Roxom y paga menos interés.
Earn
Carry Trade
Pide prestado, invierte, quédate con el spread.
Dividendos de acciones
Pagados por acciones tokenizadas.
Invertir
VIP
Seguridad
Newsroom
Más
Empresa
Sobre nosotros
Nuestro equipo directivo, misión e inversores.
Whitepaper
La visión, el propósito y la arquitectura de Roxom.
Legal
Términos, privacidad y avisos legales.
Recursos
Centro de ayuda
Guías, preguntas frecuentes y soporte.
Estado del servicio
Estado operativo de la plataforma e incidentes.
Gráfico
Finanzas
Resultados
Noticias
Acerca de
Dividendos
Insiders
Reportes
BTC
SATS
USD
1d
1s
1m
6m
YTD
1a
5a
Todo
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Gráfico
Finanzas
Resultados
Noticias
Acerca de
Dividendos
Insiders
Reportes
BTC
SATS
USD
1d
1s
1m
6m
YTD
1a
5a
Todo
Loading chart
RE
RENX.LSE
RE
Renalytix AI plc
RENX.LSE
Noticias
·
Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX
Cap. mercado
$36.5M
Volumen
91.66K
Próximos resultados
N/A
Gráfico
Finanzas
Resultados
Noticias
Acerca de
Insiders
Reportes
Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX
In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product launches, including a nationwide kidneyintelX.dkd testing program, a Humanity Biological Age wellness add-on on questhealth.com, and expanded AD-Detect blood…
finance.yahoo.com · Sep 4, 2026
Carna Health Taps Multidisciplinary Healthcare and Technology Experts to Guide the Future of Cardio-Kidney-Metabolic Care
Strategic leadership additions support Carna Health's continued global growth, building on key partnerships and positioning the company for U.S. market entry BOSTON, August 27, 2026--(BUSINESS WIRE)--Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney…
finance.yahoo.com · Aug 27, 2026
Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
Definitive agreement to accelerate adoption of Renalytix's FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient outcomes NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Renalytix plc (LSE: RENX) (OTCQB: RNLXY), today announced an…
finance.yahoo.com · Sep 15, 2025
MVP Health Care partners with Renalytix for kidney disease risk testing
NEW YORK - MVP Health Care and Renalytix plc (LSE:RENX) (OTCQB:RNLXY) announced Thursday a partnership to provide kidneyintelX.dkd testing to MVP’s 700,000 members in the northeastern United States. The collaboration aims to mitigate the progression of chronic kidney disease in M…
investing.com · Jul 17, 2025
New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
Renalytix plc Electronic health record deployment of KidneyIntelX was associated with clinical actions that slowed progression of chronic kidney disease and improved Type 2 diabetes control in just 12 months Results demonstrated a 61% increase in preventative drug prescriptions a…
finance.yahoo.com · Jan 10, 2024
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
Renalytix plc LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and…
finance.yahoo.com · Nov 14, 2023
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value…
globenewswire.com · Nov 14, 2023
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
Renalytix plc LONDON and SALT LAKE CITY, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2024 financial results on Tuesday, November 14, 2023, before market open. The Company will host a corres…
finance.yahoo.com · Nov 7, 2023
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
LONDON and SALT LAKE CITY, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2024 financial results on Tuesday, November 14, 2023, before market open. The Company will host a corresponding confer…
globenewswire.com · Nov 7, 2023
What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock
Renalytix AI PLC Sponsored ADR (RNLX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.…
finance.yahoo.com · Oct 16, 2023
Tenencias
Órdenes abiertas (0)
Posiciones (0)
Historial de órdenes
Dividendos
Transferencias
Iniciar sesión
para empezar a operar
RE
RENX.LSE
Renalytix AI plc
Comprar
Vender
Mercado
Límite
Pronto
RENX.LSE
25%
50%
75%
Máx.
Pagar con
—
Empezar a operar
Saldo disponible
0,00
Tu posición
Aún no tienes RENX.LSE.
Tickers relacionados
Resultados